{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T05:29:06Z","timestamp":1791178146514,"version":"4.1.0"},"reference-count":65,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"7th Framework Program of the European Union FIGHT-MG","award":["242210"],"award-info":[{"award-number":["242210"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.autrev.2013.09.007","type":"journal-article","created":{"date-parts":[[2013,10,11]],"date-time":"2013-10-11T02:36:31Z","timestamp":1381458991000},"page":"187-196","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["T cells from autoimmune patients display reduced sensitivity to immunoregulation by mesenchymal stem cells: Role of IL-2"],"prefix":"10.1016","volume":"13","author":[{"given":"Eyal","family":"Ben-Ami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariel","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Berrih-Aknin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2013.09.007_bb0005","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/ni1507","article-title":"Multiple sclerosis: a complicated picture of autoimmunity","volume":"8","author":"McFarland","year":"2007","journal-title":"Nat Immunol"},{"key":"10.1016\/j.autrev.2013.09.007_bb0010","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1196\/annals.1405.019","article-title":"Regulatory and pathogenic mechanisms in human autoimmune myasthenia gravis","volume":"1132","author":"Le Panse","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.autrev.2013.09.007_bb0015","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1006\/jaut.1995.0011","article-title":"Myasthenia gravis, a model of organ-specific autoimmune disease","volume":"8","author":"Berrih-Aknin","year":"1995","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2013.09.007_bb0020","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.autrev.2013.03.010","article-title":"Etiology of myasthenia gravis: innate immunity signature in pathological thymus","volume":"12","author":"Cavalcante","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2013.09.007_bb0025","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0165-5728(94)90044-2","article-title":"Acetylcholine receptor-reactive T cells in myasthenia gravis: evidence for the involvement of different subpopulations of T helper cells","volume":"50","author":"Yi","year":"1994","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2013.09.007_bb0030","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2174\/1568010053586264","article-title":"The role of CD8(+) T cells in Multiple Sclerosis and its animal models","volume":"4","author":"Goverman","year":"2005","journal-title":"Curr Drug Targets Inflamm Allergy"},{"key":"10.1016\/j.autrev.2013.09.007_bb0035","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0074-7742(07)79003-7","article-title":"The role of CD4 T cells in the pathogenesis of multiple sclerosis","volume":"79","author":"Chitnis","year":"2007","journal-title":"Int Rev Neurobiol"},{"key":"10.1016\/j.autrev.2013.09.007_bb0040","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1182\/blood-2003-11-3900","article-title":"Functional defect of regulatory CD4(+)CD25+ T cells in the thymus of patients with autoimmune myasthenia gravis","volume":"105","author":"Balandina","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2013.09.007_bb0045","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1002\/eji.200526065","article-title":"Reduced suppressive effect of CD4+CD25high regulatory T cells on the T cell immune response against myelin oligodendrocyte glycoprotein in patients with multiple sclerosis","volume":"35","author":"Haas","year":"2005","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.autrev.2013.09.007_bb0050","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s10875-008-9236-x","article-title":"Multiple Sclerosis and regulatory T cells","volume":"28","author":"Costantino","year":"2008","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.autrev.2013.09.007_bb0055","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.autrev.2013.03.009","article-title":"Impairment of regulatory T cells in myasthenia gravis: studies in an experimental model","volume":"12","author":"Gertel-Lapter","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2013.09.007_bb0060","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/nrrheum.2012.149","article-title":"T cells out of control\u2013impaired immune regulation in the inflamed joint","volume":"9","author":"Wehrens","year":"2013","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2013.09.007_bb0065","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/nri2395","article-title":"Mesenchymal stem cells in health and disease","volume":"8","author":"Uccelli","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.autrev.2013.09.007_bb0070","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.autrev.2011.01.005","article-title":"Mesenchymal stem cells as an immunomodulatory therapeutic strategy for autoimmune diseases","volume":"10","author":"Ben-Ami","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2013.09.007_bb0075","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1182\/blood-2004-04-1559","article-title":"Human mesenchymal stem cells modulate allogeneic immune cell responses","volume":"105","author":"Aggarwal","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2013.09.007_bb0080","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1182\/blood-2004-09-3696","article-title":"Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells","volume":"105","author":"Glennie","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2013.09.007_bb0085","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1089\/scd.2009.0076","article-title":"The negative co-signaling molecule b7-h4 is expressed by human bone marrow-derived mesenchymal stem cells and mediates its T-cell modulatory activity","volume":"19","author":"Xue","year":"2010","journal-title":"Stem Cells Dev"},{"key":"10.1016\/j.autrev.2013.09.007_bb0090","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1634\/stemcells.2007-0068","article-title":"Human mesenchymal stem cells promote survival of T cells in a quiescent state","volume":"25","author":"Benvenuto","year":"2007","journal-title":"Stem Cells"},{"key":"10.1016\/j.autrev.2013.09.007_bb0095","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jaut.2007.12.008","article-title":"Cell and gene therapy using mesenchymal stem cells (MSCs)","volume":"30","author":"Ozawa","year":"2008","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2013.09.007_bb0100","doi-asserted-by":"crossref","first-page":"667","DOI":"10.3727\/096368910X508762","article-title":"Mesenchymal stem cells: mechanisms of immunomodulation and homing","volume":"19","author":"Yagi","year":"2010","journal-title":"Cell Transplant"},{"key":"10.1016\/j.autrev.2013.09.007_bb0105","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1182\/blood-2005-04-1496","article-title":"Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy","volume":"106","author":"Zappia","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2013.09.007_bb0110","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s12031-009-9302-8","article-title":"Intracerebroventricular transplantation of human mesenchymal stem cells induced to secrete neurotrophic factors attenuates clinical symptoms in a mouse model of multiple sclerosis","volume":"41","author":"Barhum","year":"2010","journal-title":"J Mol Neurosci"},{"key":"10.1016\/j.autrev.2013.09.007_bb0115","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1089\/scd.2012.0463","article-title":"Human umbilical cord stem cells ameliorate experimental autoimmune encephalomyelitis by regulating immunoinflammation and remyelination","volume":"22","author":"Liu","year":"2013","journal-title":"Stem Cells Dev"},{"key":"10.1016\/j.autrev.2013.09.007_bb0120","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/s12031-012-9805-6","article-title":"Transplantation of placenta-derived mesenchymal stem cells in the EAE mouse model of ms","volume":"48","author":"Fisher-Shoval","year":"2012","journal-title":"J Mol Neurosci"},{"key":"10.1016\/j.autrev.2013.09.007_bb0125","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/ana.21076","article-title":"Mesenchymal stem cells effectively modulate pathogenic immune response in experimental autoimmune encephalomyelitis","volume":"61","author":"Gerdoni","year":"2007","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2013.09.007_bb0130","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jneuroim.2008.12.005","article-title":"Administration of bone marrow stromal cells ameliorates experimental autoimmune myasthenia gravis by altering the balance of Th1\/Th2\/Th17\/Treg cell subsets through the secretion of TGF-beta","volume":"207","author":"Kong","year":"2009","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2013.09.007_bb0135","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/j.1365-3083.2010.02445.x","article-title":"Intravenous administration of bone marrow mesenchymal stem cells benefits experimental autoimmune myasthenia gravis mice through an immunomodulatory action","volume":"72","author":"Yu","year":"2010","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.autrev.2013.09.007_bb0140","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1002\/art.24405","article-title":"Treatment of experimental arthritis by inducing immune tolerance with human adipose-derived mesenchymal stem cells","volume":"60","author":"Gonz\u00e1lez","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2013.09.007_bb0145","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1002\/eji.200425405","article-title":"Bone marrow mesenchymal progenitor cells inhibit lymphocyte proliferation by activation of the programmed death 1 pathway","volume":"35","author":"Augello","year":"2005","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.autrev.2013.09.007_bb0150","doi-asserted-by":"crossref","first-page":"17438","DOI":"10.1073\/pnas.0608249103","article-title":"Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD\/scid mice","volume":"103","author":"Lee","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2013.09.007_bb0155","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jaut.2008.10.004","article-title":"Autologous bone marrow-derived rat mesenchymal stem cells promote PDX-1 and insulin expression in the islets, alter T cell cytokine pattern and preserve regulatory T cells in the periphery and induce sustained normoglycemia","volume":"32","author":"Boumaza","year":"2009","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2013.09.007_bb0160","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/cmi.2008.52","article-title":"Transplantation of human bone marrow mesenchymal stem cell ameliorates the autoimmune pathogenesis in MRL\/lpr mice","volume":"5","author":"Zhou","year":"2008","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.autrev.2013.09.007_bb0165","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1002\/stem.68","article-title":"Mesenchymal stem cell transplantation reverses multiorgan dysfunction in systemic lupus erythematosus mice and humans","volume":"27","author":"Sun","year":"2009","journal-title":"Stem Cells"},{"key":"10.1016\/j.autrev.2013.09.007_bb0170","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1365-2249.2010.04158.x","article-title":"Allogeneic mesenchymal stem cells do not protect NZBxNZW F1 mice from developing lupus disease","volume":"161","author":"Youd","year":"2010","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2013.09.007_bb0175","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1002\/art.27560","article-title":"Interferon-\u03b3\u2013dependent inhibition of B cell activation by bone marrow\u2013derived mesenchymal stem cells in a murine model of systemic lupus erythematosus","volume":"62","author":"Schena","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2013.09.007_bb0180","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1182\/blood-2011-11-391144","article-title":"Allogeneic mesenchymal stem cell treatment alleviates experimental and clinical Sjogren syndrome","volume":"120","author":"Xu","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2013.09.007_bb0185","doi-asserted-by":"crossref","first-page":"e38615","DOI":"10.1371\/journal.pone.0038615","article-title":"Mesenchymal stromal cells improve salivary function and reduce lymphocytic infiltrates in mice with Sj\u00f6gren's-like disease","volume":"7","author":"Khalili","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2013.09.007_bb0190","doi-asserted-by":"crossref","first-page":"4640","DOI":"10.1242\/jcs.108860","article-title":"Human mesenchymal stem cells shift CD8+ T cells towards a suppressive phenotype by inducing tolerogenic monocytes","volume":"125","author":"Hof-Nahor","year":"2012","journal-title":"J Cell Sci"},{"key":"10.1016\/j.autrev.2013.09.007_bb0195","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/14653240600855905","article-title":"Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement","volume":"8","author":"Dominici","year":"2006","journal-title":"Cytotherapy"},{"key":"10.1016\/j.autrev.2013.09.007_bb0200","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/ana.1032","article-title":"Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis","volume":"50","author":"McDonald","year":"2001","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2013.09.007_bb0205","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1182\/blood-2004-07-2921","article-title":"Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness","volume":"105","author":"Beyth","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2013.09.007_bb0210","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1016\/j.yexcr.2010.04.018","article-title":"CD14+ monocytes promote the immunosuppressive effect of human umbilical cord matrix stem cells","volume":"316","author":"Wang","year":"2010","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.autrev.2013.09.007_bb0215","doi-asserted-by":"crossref","first-page":"6617","DOI":"10.4049\/jimmunol.1002239","article-title":"Umbilical cord-derived mesenchymal stromal cells modulate monocyte function to suppress T cell proliferation","volume":"185","author":"Cutler","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2013.09.007_bb0220","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1128\/JVI.01571-07","article-title":"Downregulation of the T-cell receptor complex and impairment of T-cell activation by human herpesvirus 6u24 protein","volume":"82","author":"Sullivan","year":"2008","journal-title":"J Virol"},{"key":"10.1016\/j.autrev.2013.09.007_bb0225","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.imlet.2011.01.006","article-title":"Inhibition of T cell activation through down-regulation of TCR-CD3 expression mediated by an anti-CD90 Ab","volume":"136","author":"Nishida","year":"2011","journal-title":"Immunol Lett"},{"key":"10.1016\/j.autrev.2013.09.007_bb0230","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.jaut.2008.04.002","article-title":"The promise of stem cell and regenerative therapies for multiple sclerosis","volume":"31","author":"Payne","year":"2008","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2013.09.007_bb0235","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S1474-4422(11)70121-1","article-title":"Mesenchymal stem cells for the treatment of Multiple Sclerosis and other neurological diseases","volume":"10","author":"Uccelli","year":"2011","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.autrev.2013.09.007_bb0240","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jaut.2008.03.002","article-title":"The regulatory, inflammatory, and T cell programming roles of interleukin-2 (IL-2)","volume":"31","author":"Lan","year":"2008","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2013.09.007_bb0245","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1600-065X.2008.00697.x","article-title":"Interleukin-2 in the development and control of inflammatory disease","volume":"226","author":"Hoyer","year":"2008","journal-title":"Immunol Rev"},{"key":"10.1016\/j.autrev.2013.09.007_bb0250","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1002\/eji.201040617","article-title":"Revisiting the role of IL-2 in autoimmunity","volume":"40","author":"Dooms","year":"2010","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.autrev.2013.09.007_bb0255","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.autrev.2008.07.042","article-title":"Transcriptional regulation of IL-2 in health and autoimmunity","volume":"8","author":"Crisp\u00edn","year":"2009","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2013.09.007_bb0260","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.autrev.2013.03.006","article-title":"Novel future therapeutic options in Myasthenia Gravis","volume":"12","author":"Dalakas","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2013.09.007_bb0265","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.autrev.2011.06.004","article-title":"Autoimmunity in 2010","volume":"10","author":"Selmi","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2013.09.007_bb0270","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1186\/ar2103","article-title":"Immunomodulatory properties of mesenchymal stem cells: a review based on an interdisciplinary meeting held at the Kennedy Institute of Rheumatology Division, London, UK, 31 October 2005","volume":"9","author":"Tyndall","year":"2007","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2013.09.007_bb0275","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1001\/archneur.65.6.753","article-title":"Neuroprotection and immunomodulation with mesenchymal stem cells in chronic experimental autoimmune encephalomyelitis","volume":"65","author":"Kassis","year":"2008","journal-title":"Arch Neurol"},{"key":"10.1016\/j.autrev.2013.09.007_bb0280","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.1182\/blood.V99.10.3838","article-title":"Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli","volume":"99","author":"Di Nicola","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2013.09.007_bb0285","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1182\/blood.V99.5.1610","article-title":"Bone marrow progenitor cell reserve and function and stromal cell function are defective in rheumatoid arthritis: evidence for a tumor necrosis factor alpha-mediated effect","volume":"99","author":"Papadaki","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2013.09.007_bb0290","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1038\/sj.bmt.1705179","article-title":"Normal bone marrow hematopoietic stem cell reserves and normal stromal cell function support the use of autologous stem cell transplantation in patients with multiple sclerosis","volume":"36","author":"Papadaki","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.autrev.2013.09.007_bb0295","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1093\/rheumatology\/kel267","article-title":"Bone marrow mesenchymal stromal cells (BM-MSCs) from healthy donors and auto-immune disease patients reduce the proliferation of autologous- and allogeneic-stimulated lymphocytes in vitro","volume":"46","author":"Bocelli-Tyndall","year":"2007","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2013.09.007_bb0300","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jneuroim.2008.05.006","article-title":"Differences in mesenchymal stem cell cytokine profiles between MS patients and healthy donors: implication for assessment of disease activity and treatment","volume":"199","author":"Mazzanti","year":"2008","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2013.09.007_bb0305","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1002\/art.22698","article-title":"Impairment of endothelial cell differentiation from bone marrow-derived mesenchymal stem cells: new insight into the pathogenesis of systemic sclerosis","volume":"56","author":"Cipriani","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2013.09.007_bb0310","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1136\/ard.2007.071233","article-title":"Phenotypical and functional characteristics of in vitro expanded bone marrow mesenchymal stem cells from patients with systemic sclerosis","volume":"67","author":"Larghero","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2013.09.007_bb0315","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/826182","article-title":"Gene expression profile reveals abnormalities of multiple signaling pathways in mesenchymal stem cell derived from patients with systemic lupus erythematosus","author":"Tang","year":"2012","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.autrev.2013.09.007_bb0330","article-title":"Activated NF-?B in bone marrow mesenchymal stem cells from systemic lupus erythematosus patients inhibits osteogenic differentiation through downregulating smad signaling","author":"Tang","year":"2012","journal-title":"Stem Cells Dev"},{"key":"10.1016\/j.autrev.2013.09.007_bb0325","doi-asserted-by":"crossref","first-page":"17438","DOI":"10.1073\/pnas.0608249103","article-title":"Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD\/scid mice","volume":"103","author":"Lee","year":"2006","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997213001717?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997213001717?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,8]],"date-time":"2022-03-08T19:28:39Z","timestamp":1646767719000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997213001717"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":65,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S1568997213001717"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2013.09.007","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"T cells from autoimmune patients display reduced sensitivity to immunoregulation by mesenchymal stem cells: Role of IL-2","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2013.09.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}